BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19176618)

  • 1. Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle.
    Juleff N; Windsor M; Lefevre EA; Gubbins S; Hamblin P; Reid E; McLaughlin K; Beverley PC; Morrison IW; Charleston B
    J Virol; 2009 Apr; 83(8):3626-36. PubMed ID: 19176618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle.
    Carr BV; Lefevre EA; Windsor MA; Inghese C; Gubbins S; Prentice H; Juleff ND; Charleston B
    J Gen Virol; 2013 Jan; 94(Pt 1):97-107. PubMed ID: 23034593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of long-lasting memory foot-and-mouth disease (FMD) virus serotype O-specific CD4
    Mitoma S; Carr BV; Harvey Y; Moffat K; Sekiguchi S; Charleston B; Norimine J; Seago J
    Immunology; 2021 Oct; 164(2):266-278. PubMed ID: 34003490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective in vivo depletion of T cell subpopulations and loss of memory cells in cattle using mouse monoclonal antibodies.
    Naessens J; Scheerlinck JP; De Buysscher EV; Kennedy D; Sileghem M
    Vet Immunol Immunopathol; 1998 Jul; 64(3):219-34. PubMed ID: 9730218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization.
    He Y; Li K; Wang L; Sun Z; Cao Y; Li P; Sun P; Bao H; Zhou S; Wang S; Bai X; Liu X; Zhao L; Fan X; Liu Z; Lu Z; Yang C; Lou Z
    J Virol; 2021 Nov; 95(24):e0130821. PubMed ID: 34586859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.
    Rodriguez LL; Barrera J; Kramer E; Lubroth J; Brown F; Golde WT
    Vaccine; 2003 Sep; 21(25-26):3751-6. PubMed ID: 12922108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle.
    Li K; He Y; Wang L; Li P; Wang S; Sun P; Bao H; Cao Y; Liu X; Zhu G; Song Y; Bai X; Ma X; Fu Y; Yuan H; Zhang J; Wang J; Chen Y; Li D; Lou Z; Liu Z; Lu Z
    J Virol; 2021 Oct; 95(21):e0088121. PubMed ID: 34406868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a multiplex Luminex assay for detecting swine antibodies to structural and nonstructural proteins of foot-and-mouth disease virus in Taiwan.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Tseng CH; Tsai HJ
    J Microbiol Immunol Infect; 2016 Apr; 49(2):196-207. PubMed ID: 25074628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.
    Chaudhri G; Tahiliani V; Eldi P; Karupiah G
    J Virol; 2015 Feb; 89(3):1889-99. PubMed ID: 25428875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.
    Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B
    Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle.
    Pega J; Bucafusco D; Di Giacomo S; Schammas JM; Malacari D; Capozzo AV; Arzt J; Pérez-Beascoechea C; Maradei E; Rodríguez LL; Borca MV; Pérez-Filgueira M
    J Virol; 2013 Mar; 87(5):2489-95. PubMed ID: 23255811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes.
    Höhlich BJ; Wiesmüller KH; Haas B; Gerner W; Correa R; Hehnen HR; Schlapp T; Pfaff E; Saalmüller A
    J Gen Virol; 2003 Dec; 84(Pt 12):3315-3324. PubMed ID: 14645912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus.
    Oldham G; Bridger JC; Howard CJ; Parsons KR
    J Virol; 1993 Aug; 67(8):5012-9. PubMed ID: 8392626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.